These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 216585)

  • 1. Charge-shift electrophoresis of apolipoproteins from normal humans and patients with Tangier disease.
    Utermann G; Beisiegel U
    FEBS Lett; 1979 Jan; 97(2):245-8. PubMed ID: 216585
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal apoprotein A-I isoprotein composition in patients with Tangier disease.
    Zannis VI; Lees AM; Lees RS; Breslow JL
    J Biol Chem; 1982 May; 257(9):4978-86. PubMed ID: 7068673
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunochemical study of the plasma low and high density lipoproteins in Tangier disease.
    Dumon MF; Visvikis S; Manabe T; Clerc M
    FEBS Lett; 1986 May; 201(1):163-7. PubMed ID: 3086124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High density lipoprotein infusion and partial plasma exchange in Tangier disease.
    Assmann G; Smootz E
    Eur J Clin Invest; 1978 Jun; 8(3):131-5. PubMed ID: 211037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
    Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
    Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency.
    Gustafson A; McConathy WJ; Alaupovic P; Curry MD; Persson B
    Scand J Clin Lab Invest; 1979 Jun; 39(4):377-87. PubMed ID: 230573
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
    Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
    N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alphalipoproteinemia: evaluation of the utility of its determination].
    Quintão EC
    Arq Bras Cardiol; 1980 Apr; 34(4):263-5. PubMed ID: 7436783
    [No Abstract]   [Full Text] [Related]  

  • 12. Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).
    Kay LL; Ronan R; Schaefer EJ; Brewer HB
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2485-9. PubMed ID: 6806810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I: deficiency in Tangier disease.
    Dumon MF; Clerc M; Clerc M
    Adv Exp Med Biol; 1988; 243():67-73. PubMed ID: 3146917
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
    Wang CS; Alaupovic P; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tangier disease apolipoprotein A-I compared with normal plasma A-I using monoclonal antibodies.
    Weech PK; Frohlich J; Marcel YL; N'Guyen TD; Milne RW
    Biochim Biophys Acta; 1985 Jul; 835(2):402-7. PubMed ID: 2408675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoproteins and the risk of atherosclerosis.
    Lees RS; Lees AM
    N Engl J Med; 1982 Jun; 306(25):1546-8. PubMed ID: 7078610
    [No Abstract]   [Full Text] [Related]  

  • 17. [High density lipoproteins of the blood plasma and dysalphalipoproteinemia (a review)].
    Polikarpova LI
    Vopr Med Khim; 1981; 27(5):579-90. PubMed ID: 7032061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal lipid metabolism in Tangier disease].
    Yamada N; Murase T
    Nihon Rinsho; 1983 Aug; 41(8):1817-23. PubMed ID: 6632290
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolic defect in Tangier Disease.
    Herbert PN
    N Engl J Med; 1979 Feb; 300(8):432-3. PubMed ID: 215911
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma apolipoproteins in Tangier disease, as studied with two-dimensional electrophoresis.
    Visvikis S; Dumon MF; Steinmetz J; Manabe T; Galteau MM; Clerc M; Siest G
    Clin Chem; 1987 Jan; 33(1):120-2. PubMed ID: 3100093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.